Gregory Duncan
Chief Executive Officer at VIRIOS THERAPEUTICS, INC.
Net worth: 27 524 $ as of 2024-03-30
Profile
Gregory Duncan is currently the Chairman & Chief Executive Officer at Virios Therapeutics, Inc. He is also an Independent Director at CorMedix, Inc. and a Director at Biotechnology Innovation Organization, Center for Global Health Innovation, Inc., Southeast BIO, American Psychiatric Foundation, and Biotie Therapeutics Corp.
Previously, he was the President, Chief Executive Officer & Director at Celtaxsys, Inc. from 2014 to 2020.
He was also the President-Latin America Operations & Senior VP at Pfizer Inc. from 1989 to 2007 and the Executive VP & President-North America Operations at UCB SA from 2012 to 2013.
He holds an MBA from Emory University and an undergraduate degree from State University of New York at Albany.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-25 | 57,461 ( 0.30% ) | 27 524 $ | 2024-03-30 | |
CORMEDIX INC.
-.--% | 2024-03-04 | 0 ( -.--% ) | - $ | 2024-03-30 |
Gregory Duncan active positions
| Companies | Position | Start |
|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Chief Executive Officer | 2020-03-31 |
| CORMEDIX INC. | Director/Board Member | 2020-11-01 |
Center for Global Health Innovation, Inc.
 Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Director/Board Member | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 2011-08-16 |
| American Psychiatric Foundation | Director/Board Member | - |
| Southeast BIO | Director/Board Member | - |
| Biotie Therapeutics Corp. | Director/Board Member | - |
Former positions of Gregory Duncan
| Companies | Position | End |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Executive Officer | 2020-02-29 |
| UCB | Corporate Officer/Principal | 2013-01-31 |
| ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gregory Duncan
| Emory University | Masters Business Admin |
| State University of New York at Albany | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| UCB | Health Technology |
| Private companies | 6 |
|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
| Southeast BIO | |
| American Psychiatric Foundation | |
| Biotie Therapeutics Corp. |
- Stock Market
- Insiders
- Gregory Duncan
